Current Status of Management of Malignant Disease: Current Management of Esophageal Cancer

Journal of Gastrointestinal Surgery

Volumn 19, Issue 5, 2015, Pages 964-972

  Cools Lartigue, Jonathan ^a   Spicer, Jonathan ^a   Ferri, Lorenzo E ^a  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

Adenocarcinoma; Chemoradiotherapy; Chemotherapy; Endoscopic mucosal resection; Endoscopic submucosal dissection; Enhanced recovery pathway; Esophageal cancer; Esophagectomy; Minimally invasive esophagectomy; Squamous cell carcinoma

Indexed keywords

ADJUVANT CHEMORADIOTHERAPY; ADJUVANT CHEMOTHERAPY; CANCER STAGING; ESOPHAGEAL NEOPLASMS; HUMAN; LYMPH NODE METASTASIS; MULTIMODALITY CANCER THERAPY; PATHOLOGY;

CHEMORADIOTHERAPY, ADJUVANT; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; HUMANS; LYMPHATIC METASTASIS; NEOPLASM STAGING;

EID: 84928690948     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-014-2701-3     Document Type: Article

References (61)

1. Li, Z., and Rice, T.W. 2012. Diagnosis and staging of cancer of the esophagus and esophagogastric junction. Surg Clin North Am 92:1105–1126.
2. Napier, K.J., Scheerer, M., and Misra, S. 2014. Esophageal cancer: A Review of epidemiology, pathogenesis, staging workup and treatment modalities. World J Gastrointest Oncol 6:112–120.
3. Parkin, D.M., Bray, F., Ferlay, J., and Pisani, P. 2005. Global cancer statistics, 2002. CA Cancer J Clin 55:74–108.
4. Quiros, R.M., and Bui, C.L. 2009. Multidisciplinary approach to esophageal and gastric cancer. Surg Clin North Am 89:79–96, viii.
5. Hashimi, S., and Smith, M. 2012. Medical evaluation of patients preparing for an esophagectomy. Surg Clin North Am 92:1127–1133.
6. Ell, C., May, A., Pech, O., Gossner, L., Guenter, E., Behrens, A., Nachbar, L., Huijsmans, J., Vieth, M., and Stolte, M. 2007. Curative endoscopic resection of early esophageal adenocarcinomas (Barrett’s cancer). Gastrointest Endosc 65:3–10.
7. Manner, H., Pech, O., Heldmann, Y., May, A., Pohl, J., Behrens, A., Gossner, L., Stolte, M., Vieth, M., and Ell, C. 2013. Efficacy, safety, and long-term results of endoscopic treatment for early stage adenocarcinoma of the esophagus with low-risk sm1 invasion. Clin Gastroenterol Hepatol 11:630–635; quiz e645.
8. Pech, O., May, A., Manner, H., Behrens, A., Pohl, J., Weferling, M., Hartmann, U., Manner, N., Huijsmans, J., Gossner, L., et al. 2014. Long-term efficacy and safety of endoscopic resection for patients with mucosal adenocarcinoma of the esophagus. Gastroenterology 146:652–660 e651.
9. Pech, O., May, A., Rabenstein, T., and Ell, C. 2007. Endoscopic resection of early oesophageal cancer. Gut 56:1625–1634.
10. Sjoquist, K.M., Burmeister, B.H., Smithers, B.M., Zalcberg, J.R., Simes, R.J., Barbour, A., Gebski, V., and Australasian Gastro-Intestinal Trials, G. 2011. Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis. Lancet Oncol 12:681–692.
11. Monisha Sudarshan, W.C.H., Lorenzo E Ferri. 2014. Dysphagia. In The Art and Science of Palliative Medicine. H.S.S.J.G. Pilitsis, editor: AME publishing Company.
12. Bergquist, H., Wenger, U., Johnsson, E., Nyman, J., Ejnell, H., Hammerlid, E., Lundell, L., and Ruth, M. 2005. Stent insertion or endoluminal brachytherapy as palliation of patients with advanced cancer of the esophagus and gastroesophageal junction. Results of a randomized, controlled clinical trial. Dis Esophagus 18:131–139.
13. Espino, A., Cirocco, M., Dacosta, R., and Marcon, N. 2014. Advanced imaging technologies for the detection of dysplasia and early cancer in barrett esophagus. Clin Endosc 47:47–54.
14. Vazquez-Sequeiros, E. 2010. Optimal staging of esophageal cancer.
15. Rice, T.W., Blackstone, E.H., and Rusch, V.W. 2010. 7th edition of the AJCC Cancer Staging Manual: esophagus and esophagogastric junction. Ann Surg Oncol 17:1721–1724.
16. Catalano, M.F., Sivak, M.V., Jr., Bedford, R.A., Falk, G.W., van Stolk, R., Presa, F., and Van Dam, J. 1995. Observer variation and reproducibility of endoscopic ultrasonography. Gastrointest Endosc 41:115–120.
17. Stahl, A., Ott, K., Weber, W.A., Becker, K., Link, T., Siewert, J.R., Schwaiger, M., and Fink, U. 2003. FDG PET imaging of locally advanced gastric carcinomas: correlation with endoscopic and histopathological findings. Eur J Nucl Med Mol Imaging 30:288–295.
18. Takahashi, H., Arimura, Y., Masao, H., Okahara, S., Tanuma, T., Kodaira, J., Kagaya, H., Shimizu, Y., Hokari, K., Tsukagoshi, H., et al. 2010. Endoscopic submucosal dissection is superior to conventional endoscopic resection as a curative treatment for early squamous cell carcinoma of the esophagus (with video). Gastrointest Endosc 72:255–264, 264 e251-252.
19. Lee, L., Ronellenfitsch, U., Hofstetter, W.L., Darling, G., Gaiser, T., Lippert, C., Gilbert, S., Seely, A.J., Mulder, D.S., and Ferri, L.E. 2013. Predicting lymph node metastases in early esophageal adenocarcinoma using a simple scoring system. J Am Coll Surg 217:191–199.
20. Hofstetter, W.L. 2014. Surgery alone or preoperative therapy in cT2N0 esophageal cancer. American Association for Thoracic Surgery
21. Mariette C, S.J., Maillard E, et al. 2010. Surgery alone versus chemoradiotherapy followed by surgery for localized esophageal cancer: Analysis of a randomized controlled phase III trial FFCD 9901 (abstract 4005). J Clin Oncol
22. Kelsen, D.P., Ginsberg, R., Pajak, T.F., Sheahan, D.G., Gunderson, L., Mortimer, J., Estes, N., Haller, D.G., Ajani, J., Kocha, W., et al. 1998. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med 339:1979–1984.
23. Medical Research Council Oesophageal Cancer Working, G. 2002. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet 359:1727–1733.
24. Cunningham, D., Allum, W.H., Stenning, S.P., Thompson, J.N., Van de Velde, C.J., Nicolson, M., Scarffe, J.H., Lofts, F.J., Falk, S.J., Iveson, T.J., et al. 2006. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355:11–20.
25. Ychou, M., Boige, V., Pignon, J.P., Conroy, T., Bouche, O., Lebreton, G., Ducourtieux, M., Bedenne, L., Fabre, J.M., Saint-Aubert, B., et al. 2011. Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial. J Clin Oncol 29:1715–1721.
26. Bosset, J.F., Gignoux, M., Triboulet, J.P., Tiret, E., Mantion, G., Elias, D., Lozach, P., Ollier, J.C., Pavy, J.J., Mercier, M., et al. 1997. Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med 337:161–167.
27. Burmeister, B.H., Smithers, B.M., Gebski, V., Fitzgerald, L., Simes, R.J., Devitt, P., Ackland, S., Gotley, D.C., Joseph, D., Millar, J., et al. 2005. Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial. Lancet Oncol 6:659–668.
28. Tepper, J., Krasna, M.J., Niedzwiecki, D., Hollis, D., Reed, C.E., Goldberg, R., Kiel, K., Willett, C., Sugarbaker, D., and Mayer, R. 2008. Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. J Clin Oncol 26:1086–1092.
29. Urba, S.G., Orringer, M.B., Turrisi, A., Iannettoni, M., Forastiere, A., and Strawderman, M. 2001. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 19:305–313.
30. van Hagen, P., Hulshof, M.C., van Lanschot, J.J., Steyerberg, E.W., van Berge Henegouwen, M.I., Wijnhoven, B.P., Richel, D.J., Nieuwenhuijzen, G.A., Hospers, G.A., Bonenkamp, J.J., et al. 2012. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med 366:2074–2084.
31. Walsh, T.N., Noonan, N., Hollywood, D., Kelly, A., Keeling, N., and Hennessy, T.P. 1996. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 335:462–467.
32. Lee, J.L., Park, S.I., Kim, S.B., Jung, H.Y., Lee, G.H., Kim, J.H., Song, H.Y., Cho, K.J., Kim, W.K., Lee, J.S., et al. 2004. A single institutional phase III trial of preoperative chemotherapy with hyperfractionation radiotherapy plus surgery versus surgery alone for resectable esophageal squamous cell carcinoma. Ann Oncol 15:947–954.
33. Mariette, C., Dahan, L., Mornex, F., Maillard, E., Thomas, P.A., Meunier, B., Boige, V., Pezet, D., Robb, W.B., Le Brun-Ly, V., et al. 2014. Surgery Alone Versus Chemoradiotherapy Followed by Surgery for Stage I and II Esophageal Cancer: Final Analysis of Randomized Controlled Phase III Trial FFCD 9901. J Clin Oncol.
34. Ando, N., Iizuka, T., Ide, H., Ishida, K., Shinoda, M., Nishimaki, T., Takiyama, W., Watanabe, H., Isono, K., Aoyama, N., et al. 2003. Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan Clinical Oncology Group Study–JCOG9204. J Clin Oncol 21:4592–4596.
35. Ferri, L.E., Ades, S., Alcindor, T., Chasen, M., Marcus, V., Hickeson, M., Artho, G., and Thirlwell, M.P. 2012. Perioperative docetaxel, cisplatin, and 5-fluorouracil (DCF) for locally advanced esophageal and gastric adenocarcinoma: a multicenter phase II trial. Ann Oncol 23:1512–1517.
36. Sudarshan, M., Alcindor, T., Ades, S., Aloraini, A., van Huyse, M., Asselah, J., David, M., Frechette, D., Brisson, S., Thirlwell, M., et al. 2014. Survival and Recurrence Patterns after Neoadjuvant Docetaxel, Cisplatin, and 5-Fluorouracil (DCF) for Locally Advanced Esophagogastric Adenocarcinoma. Ann Surg Oncol.
37. Stahl, M., Walz, M.K., Stuschke, M., Lehmann, N., Meyer, H.J., Riera-Knorrenschild, J., Langer, P., Engenhart-Cabillic, R., Bitzer, M., Konigsrainer, A., et al. 2009. Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction. J Clin Oncol 27:851–856.
38. Burmeister, B.H., Thomas, J.M., Burmeister, E.A., Walpole, E.T., Harvey, J.A., Thomson, D.B., Barbour, A.P., Gotley, D.C., and Smithers, B.M. 2011. Is concurrent radiation therapy required in patients receiving preoperative chemotherapy for adenocarcinoma of the oesophagus? A randomised phase II trial. Eur J Cancer 47:354–360.
39. Spicer, J., Benay, C., Lee, L., Rousseau, M., Andalib, A., Kushner, Y., Marcus, V., and Ferri, L. 2014. Diagnostic accuracy and utility of intraoperative microscopic margin analysis of gastric and esophageal adenocarcinoma. Ann Surg Oncol 21:2580–2586.
40. Ferri, L.E., Law, S., Wong, K.H., Kwok, K.F., and Wong, J. 2006. The influence of technical complications on postoperative outcome and survival after esophagectomy. Ann Surg Oncol 13:557–564.
41. Ferri, L. 2013. Extended lymphadenectomy in gastric cancer is crucial. World J Surg 37:1768–1772.
42. Ulrich Ronellenfitsch, M., Sara Najmeh, MD, Amin Andalib, MD, Rushika M. Perera, MSc, Mathieu C. Rousseau, MD, David S. Mulder, MD, Lorenzo E. Ferri, MD, PhD 2014. Functional outcomes and quality of life after proximal gastrectomy with esophagogastrostomy using a narrow gastric conduit. Annals of Surgical Oncology In press.
43. Fok, M., and Wong, J. 1995. Cancer of the oesophagus and gastric cardia. Standard oesophagectomy and anastomotic technique. Ann Chir Gynaecol 84:179–183.
44. Law, S., Cheung, M.C., Fok, M., Chu, K.M., and Wong, J. 1997. Pyloroplasty and pyloromyotomy in gastric replacement of the esophagus after esophagectomy: a randomized controlled trial. J Am Coll Surg 184:630–636.
45. Low, D.E., and Bodnar, A. 2013. Update on clinical impact, documentation, and management of complications associated with esophagectomy. Thorac Surg Clin 23:535–550.
46. Finks, J.F., Osborne, N.H., and Birkmeyer, J.D. 2011. Trends in hospital volume and operative mortality for high-risk surgery. N Engl J Med 364:2128–2137.
47. Sudarshan, M., and Ferri, L. 2012. A critical review of minimally invasive esophagectomy. Surg Laparosc Endosc Percutan Tech 22:310–318.
48. Law, S., and Wong, J. 2004. Esophageal cancer surgery: lessons from 1,200 resections. Hawaii Med J 63:203–205.
49. Andalib, A., Ramana-Kumar, A.V., Bartlett, G., Franco, E.L., and Ferri, L.E. 2013. Influence of postoperative infectious complications on long-term survival of lung cancer patients: a population-based cohort study. J Thorac Oncol 8:554–561.
50. Rizk, N.P., Bach, P.B., Schrag, D., Bains, M.S., Turnbull, A.D., Karpeh, M., Brennan, M.F., and Rusch, V.W. 2004. The impact of complications on outcomes after resection for esophageal and gastroesophageal junction carcinoma. J Am Coll Surg 198:42–50.
51. Li, C., Ferri, L.E., Mulder, D.S., Ncuti, A., Neville, A., Lee, L., Kaneva, P., Watson, D., Vassiliou, M., Carli, F., et al. 2012. An enhanced recovery pathway decreases duration of stay after esophagectomy. Surgery 152:606–614; discussion 614–606.
52. Biere, S.S., van Berge Henegouwen, M.I., Maas, K.W., Bonavina, L., Rosman, C., Garcia, J.R., Gisbertz, S.S., Klinkenbijl, J.H., Hollmann, M.W., de Lange, E.S., et al. 2012. Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial. Lancet 379:1887–1892.
53. Ninomiya, I., Okamoto, K., Fujimura, T., Fushida, S., Osugi, H., and Ohta, T. 2014. Oncologic outcomes of thoracoscopic esophagectomy with extended lymph node dissection: 10-year experience from a single center. World J Surg 38:120–130.
54. Lee, L., Li, C., Robert, N., Latimer, E., Carli, F., Mulder, D.S., Fried, G.M., Ferri, L.E., and Feldman, L.S. 2013. Economic impact of an enhanced recovery pathway for oesophagectomy. Br J Surg 100:1326–1334.
55. Palta Manisha, W.C.G., Czito Brian. 2013. Neoadjuvant Chemotherapy or Chemoradiotherapy in Resectable Esophageal Cancer: A Lot of Data, Little Clarity.
56. American Gastroenterological, A., Spechler, S.J., Sharma, P., Souza, R.F., Inadomi, J.M., and Shaheen, N.J. 2011. American Gastroenterological Association medical position statement on the management of Barrett’s esophagus. Gastroenterology 140:1084–1091.
57. Committee, A.S.o.P., Evans, J.A., Early, D.S., Fukami, N., Ben-Menachem, T., Chandrasekhara, V., Chathadi, K.V., Decker, G.A., Fanelli, R.D., Fisher, D.A., et al. 2012. The role of endoscopy in Barrett’s esophagus and other premalignant conditions of the esophagus. Gastrointest Endosc 76:1087–1094.
58. Fitzgerald, R.C., di Pietro, M., Ragunath, K., Ang, Y., Kang, J.Y., Watson, P., Trudgill, N., Patel, P., Kaye, P.V., Sanders, S., et al. 2014. British Society of Gastroenterology guidelines on the diagnosis and management of Barrett’s oesophagus. Gut 63:7–42.
59. Wang, K.K., Sampliner, R.E., and Practice Parameters Committee of the American College of, G. 2008. Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett’s esophagus. Am J Gastroenterol 103:788–797.
60. Altorki, N., and Skinner, D. 2001. Should en bloc esophagectomy be the standard of care for esophageal carcinoma? Ann Surg 234:581–587.
61. Hulscher, J.B., van Sandick, J.W., Tijssen, J.G., Obertop, H., and van Lanschot, J.J. 2000. The recurrence pattern of esophageal carcinoma after transhiatal resection. J Am Coll Surg 191:143–148.